epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Lodine
    etodolac
  • remove Lomaira
    phentermine hydrochloride
  • remove Methylin
    methylphenidate

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Lodine (etodolac) + Lomaira (phentermine hydrochloride)

Monitor/Modify Tx


etodolac + phentermine

monitor BP: combo may incr. risk of HTN (additive effects)

Smiley face Smiley face Lodine (etodolac) + Methylin (methylphenidate)

Monitor/Modify Tx


etodolac + methylphenidate

monitor BP: combo may incr. risk of HTN (additive effects)

Smiley face Smiley face Lomaira (phentermine hydrochloride) + Methylin (methylphenidate)

Monitor/Modify Tx


phentermine + methylphenidate

monitor BP, HR: combo may incr. risk of HTN, tachycardia, CNS stimulatory effects (additive effects)

Additional Considerations

Smiley face Smiley face methylphenidate in Methylin

add MAO inhibitor to Interaction Check if recent (14 days) use

avoid combo with beverages or products containing ethanol and some ER methylphenidate formulations (including capsule, chewable, oral suspension, ODT); combo may incr. methylphenidate release rate, levels, risk of adverse effects, decr. duration of efficacy

Smiley face Smiley face phentermine in Lomaira

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information